Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

Authors: Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, Jacques Genest, Antonio M. Gotto, John J.P. Kastelein, Wolfgang Köenig, Peter Libby, Alberto Lorenzatti, Jean MacFadyen, Børge G. Nordestgaard, James Shepherd, James T. Willerson, Robert J. Glynn - The Lancet 2009 cited by 1,020